Curriculum in Neurobiology, Neuroscience Center, Neurodevelopmental Disorders Research Center, Chapel Hill, NC 27599, USA.
Prog Neurobiol. 2010 May;91(1):23-37. doi: 10.1016/j.pneurobio.2010.01.004. Epub 2010 Jan 25.
Various combinations of subunits assemble to form the NMDA-type glutamate receptor (NMDAR), generating diversity in its functions. Here we review roles of the unique NMDAR subunit, NR3A, which acts in a dominant-negative manner to suppress receptor activity. NR3A-containing NMDARs display striking regional and temporal expression specificity, and, unlike most other NMDAR subtypes, they have a low conductance, are only modestly permeable to Ca(2+), and pass current at hyperpolarized potentials in the presence of magnesium. While glutamate activates triheteromeric NMDARs composed of NR1/NR2/NR3A subunits, glycine is sufficient to activate diheteromeric NR1/NR3A-containing receptors. NR3A dysfunction may contribute to neurological disorders involving NMDARs, and the subunit offers an attractive therapeutic target given its distinct pharmacological and structural properties.
各种亚基组合形成 NMDA 型谷氨酸受体(NMDAR),从而使其功能多样化。在这里,我们回顾了独特的 NMDAR 亚基 NR3A 的作用,它以显性负性方式抑制受体活性。含有 NR3A 的 NMDAR 表现出明显的区域和时间表达特异性,与大多数其他 NMDAR 亚型不同,它们的电导低,对 Ca(2+)的通透性适中,并且在镁存在的情况下在超极化电位下通过电流。虽然谷氨酸激活由 NR1/NR2/NR3A 亚基组成的三聚体 NMDAR,但甘氨酸足以激活包含 NR1/NR3A 的二聚体受体。NR3A 功能障碍可能导致涉及 NMDAR 的神经紊乱,并且由于其独特的药理学和结构特性,该亚基提供了一个有吸引力的治疗靶标。